Impact of body mass index on progression of primary immunoglobulin a nephropathy
The role of obesity in the progression of primary glomerular diseases is controversial. A few studies report overweight/obesity as a risk factor for disease progression in immunoglobulin A nephropathy (IgAN), and the real impact of it still remains unclear. The aim of this study was to elucidate the...
Main Authors: | Shankar Prasad Nagaraju, Dharshan Rangaswamy, Aswani Srinivas Mareddy, Srikanth Prasad, Sindhu Kaza, Srinivas Shenoy, Karan Saraf, Ravindra Prabhu Attur, Rajeevalochana Parthasarathy, Srinivas Kosuru, Uday Venkat Mateti, Vasudeva Guddattu, Sindhura Lakshmi Koulmane Laxminarayana |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=2;spage=318;epage=325;aulast=Nagaraju |
Similar Items
-
Role of corticosteroid therapy in IgA nephropathy; where do we stand?
by: Shankar Prasad Nagaraju, et al.
Published: (2017-10-01) -
Efficacy and safety of a modified- ‘modified Ponticelli’ regimen for treatment of primary membranous nephropathy
by: Indu Ramachandra Rao, et al.
Published: (2019-07-01) -
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
by: Shankar Prasad Nagaraju, et al.
Published: (2023-01-01) -
Comparison of creatinine-based glomerular filtration rate estimation equations in voluntary Indian kidney donors: A single centre study
by: Shankar Prasad Nagaraju, et al.
Published: (2022-07-01) -
P27 ROLE OF CORTICOSTEROID THERAPY IN IgA NEPHROPATHY - WHERE DO WE STAND?
by: S.P. Nagaraju, et al.
Published: (2016-11-01)